Burden of Gastrointestinal Disease in the United States: 2012 Update

Abstract

Background & Aims Gastrointestinal (GI) diseases account for substantial morbidity, mortality and cost. Statistical analyses of the most recent data are necessary to guide GI research, education and clinical practice. We estimate the burden of GI disease in the US. Methods We collected information on the epidemiology of GI diseases (including cancers) and symptoms, along with data on resource utilization, quality of life, impairments to work and activity, morbidity, and mortality. These data were obtained from the National Ambulatory Medical Care Survey; National Health and Wellness Survey; Nationwide Inpatient Sample; Surveillance, Epidemiology, and End Results Program; National Vital Statistics System; Thompson Reuters MarketScan®; Medicare; Medicaid; and the Clinical Outcomes Research Initiative’s National Endoscopic Database. We estimated endoscopic use and costs and examined trends in endoscopic procedure. Results Abdominal pain was the most common gastrointestinal symptom that prompted a clinic visit (15.9 million visits). Gastroesophageal reflux was the most common GI diagnosis (8.9 million visits). Hospitalizations and mortality from Clostridium difficile infection have doubled in the last 10 years. Acute pancreatitis was the most common reason for hospitalization (274,119 discharges). Colorectal cancer accounted for more than half of all GI cancers and was the leading cause of GI-related mortality (52,394 deaths). There were 6.9 million upper, 11.5 million lower, and 228,000 biliary endoscopies performed in 2009. The total cost for outpatient gastrointestinal endoscopy examinations was $32.4 billion. Conclusions GI diseases are a source of substantial morbidity, mortality and cost in the US.

Rectal indomethacin reduces the risk of post-ERCP pancreatitis

“…1 The most significant adverse event associated with this intervention is post-ERCP pancreatitis (PEP), which has been described to occur in about 9.7% of procedures, and 14.7% of procedures in high-risk patients. 2 Since the early 1990s, prophylactic pancreatic duct stent placement (PSP) has become the standard intervention to prevent PEP.…”

The Bedside Index for Severity in Acute Pancreatitis: a systematic review of prospective studies to determine predictive performance

“…Acute pancreatitis is the most common gastrointestinal cause of hospitalization [1]. The rate of hospitalization continues to grow [2].…”

Serological diagnosis and prognosis of severe acute pancreatitis by analysis of serum glycoprotein 2

“…The serological diagnosis of acute pancreatitis, the main cause for hospitalization in case of acute abdominal pain in developed countries [1], is still a laboratory challenge [2]. The incidence of acute pancreatitis, a life-threatening disease, ranges from 17.5 to 73.4 cases per 100,000 individuals globally [2].…”